Become the program exclusively tailored specially for healthcare sysyem.
Create a direct and exclusive access to hospital resources for customized collaboration.
Raise the possibility for future funding and obtain the chances of getting the fund from BE Health Ventures.
Help teams achieve specific milestones in order to accelerate growth and expand the market in Asia.
Get 1-on-1 consults from Healthcare experts to develop a sound business model.
Taiwan’s first international medical university accelerator with a perfect medical market place, clinical advantages, biomedical and artificial intelligence talents, focusing on digital health, artificial intelligence and medical equipment, assisting start-up to raise funds , community and international resource linkage, coaching and reducing development risks, clinical trial planning, establishing medical pathways. Assist the startup teams to make good use of Taipei medical University clinical field and dedicated team of professional physicians, counsel the startup team’s product clinical verification strategy, enable the startup team to accelerate the products into the clinical field, provide entrepreneurial funds and assist in raising funds, Establish engagement with international accelerator and entrepreneurial ecosystem.
Show Chwan health care system is the largest privately-owned hospital group in Taiwan, with 10 hospitals, over 3,700 beds, and 6,000 employees. Innovation and patient-oriented service have always been its core values since being founded in 1973 by Dr Min-ho Huang. The mission is to offer leading-edge technology and services to under-served areas. In addition to tertiary medical services, it also has facilities catering to elderly, maternal health, and comprehensive cancer care. Originated from Ircad located in Strasbourg, France, it is the largest and most advanced minimally invasive training center in Asia. Established 2008, it has trained over 12,000 physicians from over 80 countries, running close to 100 workshops annually. In addition to surgical training, it also boasts an advanced research center as well as an incubation center for medical start-ups. It is the perfect hub for innovations. Located in Lugang Industrial Park, in the center of Taiwan, it is an ideal center with many resources necessary for the success of med-tech start-ups.
2025 Dec.-Jan.
Recruiting
2026 Mar.
Kick-off
2026 Late Jul.
Demo Day
2026 Feb.
Selection
2026 Mar.-Aug.
Mentorship
– Location: Average of 2h55m flight to six major cities in western Pacific.
– Medical Resources: Collected over 20 years of digitized, single- payer medical data from NHI.
– Technology: Strength in creating proprietary technology, R&D and manufacturing.
– Innovation: Taiwan is focused on having an innovation-driven economy.
The BE PoC Accelerator Program provides the ideal opportunity for international startups to explore business opportunities in Asia. With our network of hospitals, startups can explore unmet clinical needs through needs validation, establishing a hospital pilot site, and access to medical resources. Startups interested in clinical trial, manufacturing, data access and fundraising resources will also benefit from our network across Taiwan and Asia.
According to the experience from previous batches, the chances for the accelerated companies to be invested are 10%. The primary concern of the investment evaluation is whether the company can provide relevant information for us to conduct a certain degree of due diligence, while the other key aspect is the strategic synergy between BE and the company.
We conduct due diligence based on the stage of the company, and the main categories include Business, Technology, Finance, Regulation, and Legal and Related Matters. In general, it will take about three months from the first meeting to the final decision of the Investment Committee.
Since the strategic synergy between BE and the company is a key aspect of our investment evaluation, as a hospital VC, the progress of the collaboration between the companies and our two partner hospitals will play a critical role in due diligence.